Compare LIF & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LIF | AMRX |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.0B |
| IPO Year | N/A | N/A |
| Metric | LIF | AMRX |
|---|---|---|
| Price | $56.96 | $13.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $91.93 | $13.25 |
| AVG Volume (30 Days) | 803.8K | ★ 1.6M |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.12 | 0.02 |
| Revenue | $459,031,000.00 | ★ $2,934,959,000.00 |
| Revenue This Year | $30.95 | $9.99 |
| Revenue Next Year | $31.65 | $6.48 |
| P/E Ratio | ★ $157.55 | $714.51 |
| Revenue Growth | ★ 33.86 | 9.50 |
| 52 Week Low | $29.62 | $6.69 |
| 52 Week High | $112.54 | $13.49 |
| Indicator | LIF | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 27.37 | 65.78 |
| Support Level | $61.05 | $12.66 |
| Resistance Level | $66.30 | $13.34 |
| Average True Range (ATR) | 2.33 | 0.32 |
| MACD | -0.20 | -0.00 |
| Stochastic Oscillator | 0.79 | 87.01 |
Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.